1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Six-month occlusion rates including DSA and alternative follow-up with RROC
RROC Overall Study Group Group A Group B
n = 47 % n = 27 % n = 20 %
3 6 12.8 5 18.5 1 5.0
2 5 10.6 2 7.4 3 15.0
1 36 76.6 20 74.1 16 80.0
RROC	Overall Study Group		Group A		Group B
RROC	n = 47	%	n = 27	%	n = 20	%
3	6	12.8	5	18.5	1	5.0
2	5	10.6	2	7.4	3	15.0
1	36	76.6	20	74.1	16	80.0